The number of clinical practice guidelines for traditional Chinese patent medicine has been increasing recently. However, the quality of guidelines was still low compared to international guidelines. Considering the characteristics of traditional Chinese patent medicine, we suggested the following items should be taken into account when developing traditional Chinese patent medicine guidelines: ensuring the standardized guidelines of traditional Chinese patent medicine research problem is scientific based on reliable evidence; identifying the common questions according to these research problems; understanding the strength of evidence and how to recommend correctly; inviting some experts in other fields to take part in the development of guidelines; paying more attention on the changes of disease burden and the impact of new methods and technologies when developing the guideline; paying more attention to the non-consensus opinions and evidence supporting these opinions; insisting on quality is the priority, while speed is secondary.
Citation：
YU Jiajie, GAO Xuemin, LI Ping, LI Lei, YAN Meihuan, LI Youping. Considerations and suggestions for standardizing clinical practice guideline of traditional Chinese patent medicine-chronic renal disease as an example. Chinese Journal of Evidence-Based Medicine, 2019, 19(12): 1477-1480. doi: 10.7507/1672-2531.201811001
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
| 1. |
Institute of Medicine. Clinical practice guidelines: directions for a new program. Washington DC: National Academy Press, 1990.
|
| 2. |
IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington DC: Te National Academies Press, 2011.
|
| 3. |
Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
|
| 4. |
陈耀龙, 周齐, 崔蓉蓉, 等. 基于AGREE Ⅱ的中医药临床指南质量评价. 中国循证医学杂志, 2016, 16(11): 1331-1337.
|
| 5. |
Institute for health metrics and evaluation. GBD compare. Available at: https://vizhub.healthdata.org/gbd-compare/.
|
| 6. |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2095-2128.
|
| 7. |
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.
|
| 8. |
上海慢性肾脏病早发现及规范化诊治与示范项目专家组. 慢性肾脏病筛查、诊断及防治指南. 中国实用内科杂志, 2017, 37(1): 28-34.
|
| 9. |
周海姗. 慢性肾脏病的中医药诊疗进展. 实用中医内科杂志, 2012, 26(4): 6-11.
|
| 10. |
王少华, 郭华伟, 关光普, 等. 中医系统干预综合治疗慢性肾脏病思路与方法. 辽宁中医杂志, 2010, 10(2): 250-251.
|
- 1. Institute of Medicine. Clinical practice guidelines: directions for a new program. Washington DC: National Academy Press, 1990.
- 2. IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington DC: Te National Academies Press, 2011.
- 3. Chen Y, Wang C, Shang H, et al. Clinical practice guidelines in China. BMJ, 2018, 360: j5158.
- 4. 陈耀龙, 周齐, 崔蓉蓉, 等. 基于AGREE Ⅱ的中医药临床指南质量评价. 中国循证医学杂志, 2016, 16(11): 1331-1337.
- 5. Institute for health metrics and evaluation. GBD compare. Available at: https://vizhub.healthdata.org/gbd-compare/.
- 6. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2095-2128.
- 7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.
- 8. 上海慢性肾脏病早发现及规范化诊治与示范项目专家组. 慢性肾脏病筛查、诊断及防治指南. 中国实用内科杂志, 2017, 37(1): 28-34.
- 9. 周海姗. 慢性肾脏病的中医药诊疗进展. 实用中医内科杂志, 2012, 26(4): 6-11.
- 10. 王少华, 郭华伟, 关光普, 等. 中医系统干预综合治疗慢性肾脏病思路与方法. 辽宁中医杂志, 2010, 10(2): 250-251.
